Dr. Sundar Ramanan, Global Head of Regulatory Affairs, Biocon Biologics Dr. Sundar Ramanan, Vice President & Head, Global Regulatory Affairs, Biocon Biologics, presented on behalf of the Company at the public meeting for the reauthorization process for the Biosimilar User Fee Act (BsUFA III) program organized by the U.S. Food and Drug Administration (FDA) on … Continue reading Biosimilars Regulatory Framework Must Evolve in Line with Emerging Scientific Evidence
Women in Boardrooms
“It’s so weird to see how people can change so suddenly, how they take interest in me now that I’m rising to the top, yet didn’t support me when I was starting out.” said Sakshi Malik, Indian wrestler Sakshi Malik became the first Indian woman to win an Olympic medal in wrestling, at the 2016 … Continue reading Women in Boardrooms
GST to Foster Supply Chain Operational Efficiency
Prasad Deshpande, Vice President & Head, SCM, Biocon shares his views on the impact of GST on Supply Chain in Pharma Sector.
Digital India Can Propel Us to Double-Digit Growth
Kiran Mazumdar-Shaw shares her views on how #digitalindia can transform lives, boost growth & propel us to double digit growth.
Biocon: Creating Value through Incisive IP Strategy
Arshad Jamil, General Manager, IPR, Biocon talks about Biocon's IP strategy that is creating value by leveraging the potential of our innovative products & processes.
A Balanced Budget That Plays It Safe
Kiran Mazumdar Shaw, CMD, Biocon shares her views on #Budget2017
Strategic HR for Today’s Biotech M&As
Amitava Saha, Sr. VP & Head HR, Biocon shares his views on the role of Strategic HR in ensuring the success of today’s biotech M&As.
Why It’s Imperative To Look At The Impact Of Tax SOPs
By Kiran Mazumdar Shaw
Chairman & Managing Director,
Biocon Limited.
Innovation, Not Price Control is the Answer to Affordable Bt Cotton Technology
By Kiran Mazumdar Shaw
Chairman & Managing Director,
Biocon Limited.
A Blog by Biocon 